Alcobra Ltd. (ADHD) announced that its investigational New Drug Applications for drug candidate MDX in Attention Deficit Hyperactivity Disorder and Fragile X Syndrome have been put on full clinical hold, following adverse neurological findings in a pre-clinical study.
from RTT - Before the Bell http://ift.tt/2cQpa1U
via IFTTT
No comments:
Post a Comment